Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus to delay renal fibrosis in IgG4-related kidney disease
ChiCTR2300078767Phase 4Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sirolimus in IgG4-related kidney disease (IgG4-RKD), sponsored by Peking Union Medical College Hospital. Primary endpoint: Estimated glomerular filtration rate (eGFR). Started Dec 2023; status: recruiting.
02
Drugs
sirolimus
03
Conditions
IgG4-related kidney disease (IgG4-RKD)
Beyond the preview
Go deeper on ChiCTR2300078767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078767.